A Multicenter Evaluation of a Point-of-Care Blood Glucose Meter System in Critically Ill Patients
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Background: Our purpose was to evaluate the performance of the ACCU-CHEK® Inform II blood glucose monitoring system (Roche Diagnostics GmbH) compared with the perchloric acid hexokinase (PCA-HK) comparator method on the cobas® 6000 analyzer (Roche Diagnostics International Ltd) in critically ill patients. Methods: Overall, 476 arterial (376 pediatric/adult, 100 neonate), 375 venous, and 100 neonatal heel-stick whole-blood samples were collected and evaluated from critical care settings at 10 US hospitals, including the emergency department, medical and surgical intensive care units (ICUs), and neonatal and pediatric ICUs. The ACCU-CHEK Inform II system was evaluated at 2 cutoff boundaries: boundary 1 was ≥95% of results within ±12 mg/dL of the reference (samples with blood glucose <75 mg/dL) or ±12% of the reference (glucose ≥75 mg/dL), and boundary 2 was ≥98% of results within ±15 mg/dL or ±15% of the reference. Clinical performance was assessed by evaluating sample data using Parkes error grid, Monte Carlo simulation, and sensitivity and specificity analyses to estimate clinical accuracy and implications for insulin dosing when using the ACCU-CHEK Inform II system. Results: Proportions of results within evaluation boundaries 1 and 2, respectively, were 96% and 98% for venous samples, 94% and 97% for pediatric and adult arterial samples, 84% and 98% for neonatal arterial samples, and 96% and 100% for neonatal heel-stick samples. Clinical evaluation demonstrated high specificity and sensitivity, with low risk of potential insulin-dosing errors. Conclusions: The ACCU-CHEK Inform II system demonstrated clinically acceptable performance against the PCA-HK reference method for blood glucose monitoring in a diverse population of critically ill patients in US care settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Meters that are designed for professional use have been shown in published studies to be accurate on samples of whole blood (129-131).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977 · cited 1×
“The landmark Leuven trials (6, 7) suggested that strict glycemic control via intensive insulin therapy could reduce morbidity and mortality in critically ill patients, prompting intensive therapy strategies to achieve normoglycemia in ICU settings (8, 9).”
BackgroundIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“The landmark Leuven trials (6, 7) suggested that strict glycemic control via intensive insulin therapy could reduce morbidity and mortality in critically ill patients, prompting intensive therapy strategies to achieve normoglycemia in ICU settings (8, 9).”
BackgroundHypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009 · cited 2×
“However, intensive insulin therapy can increase the risk of hypoglycemia in critically ill patients, which carries an independent risk of increased morbidity and mortality and is associated with significantly extended ICU stays (8, 10).”
BackgroundBode, B., Garrett, V., Messler, J., McFarland, R., Crowe, J., Booth, R., & Klonoff, D. C. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820924469 · Cited by 766 · cited 2×
“Not reported/unknown 1 (<1) 11 (2) 0 12 (1)”
Stress hyperglycemia: an essential survival response!
Marik, P. E., & Bellomo, R. (2013) · Critical Care · doi:10.1186/cc12514 · Cited by 729 · cited 1×
“Intermittent, capillary-based measurement is labor intensive, and large glucose fluctuations may go unnoticed between readings (2, 5, 12, 13).”
BackgroundGlucose Meters: A Review of Technical Challenges to Obtaining Accurate Results
Tonyushkina, K., & Nichols, J. H. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300446 · Cited by 406 · cited 5×
“Methods: Overall, 476 arterial (376 pediatric/adult, 100 neonate), 375 venous, and 100 neonatal heel-stick whole-blood samples were collected and evaluated from critical care settings at 10 US hospitals, including the emergency department, medical and surgical intensive care units (ICUs), and neonatal and pediatric IC…”
BackgroundInfluentialSelf-citationManagement of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391 · cited 1×
“Hispanic/Latino 91 (24) 52 (11) 3 (3) 146 (15)”
Real-Time Continuous Glucose Monitoring in Critically Ill Patients
Holzinger, U., Warszawska, J., Kitzberger, R., Wewalka, M., Miehsler, W., Herkner, H., & Madl, C. (2010) · Diabetes Care · doi:10.2337/dc09-1352 · Cited by 212
The Accuracy of Point-of-Care Glucose Measurements
Rebel, A., Rice, M. A., & Fahy, B. G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600228 · Cited by 144 · cited 3×
“Black/African American 80 (21) 63 (13) 36 (36) 179 (19)”
BackgroundTechnical Aspects of the Parkes Error Grid
Pfützner, A., Klonoff, D. C., Pardo, S., & Parkes, J. L. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700517 · Cited by 122 · cited 4×
“Hispanic/Latino 91 (24) 52 (11) 3 (3) 146 (15)”
BackgroundInfluentialAn Overview of Hypoglycemia in the Critically Ill
Lacherade, J.-C., Jacqueminet, S., & Preiser, J.-C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300603 · Cited by 86 · cited 3×
“Hispanic/Latino 91 (24) 52 (11) 3 (3) 146 (15)”
BackgroundMild hypoglycemia is strongly associated with increased intensive care unit length of stay
Krinsley, J., Schultz, M. J., Spronk, P. E., van Braam Houckgeest, F., van der Sluijs, J. P., Mélot, C., & Preiser, J.-C. (2011) · Annals of Intensive Care · doi:10.1186/2110-5820-1-49 · Cited by 82 · cited 1×
“However, intensive insulin therapy can increase the risk of hypoglycemia in critically ill patients, which carries an independent risk of increased morbidity and mortality and is associated with significantly extended ICU stays (8, 10).”
BackgroundGlucose control in critical care
Clain, J. M., Ramar, K., & Surani, S. R. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i9.1082 · Cited by 65 · cited 4×
“Not reported/unknown 6 (2) 11 (2) 0 17 (2)”
BackgroundInfluentialDuBois, J. A., Slingerland, R. J., Fokkert, M., Roman, A., Tran, N. K., Clarke, W., Sartori, D. A., Palmieri, T. L., Malic, A., Lyon, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002252 · Cited by 59 · cited 12×
“When examined alongside neonatal arterial sample data for the similar FDA-approved pointof-care system by DuBois et al. (25), our findings appear in a positive light.”
BackgroundMethodResultInfluentialSelf-citationAndreis, E., Küllmer, K., & Appel, M. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814523886 · Cited by 22 · cited 1×
“It is directly linked to the higher-order isotope dilution GC-MS method by calibration (23).”
MethodBlood Glucose Measurements in Critically Ill Patients
Herpe, T. V., & Mesotten, D. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600104 · Cited by 20
Intensive glucose control for critically ill patients: an updated meta-analysis
Fu, Y., Sun, Y., Zhang, J., & Cheng, Y. (2018) · Endocrine Connections · doi:10.1530/ec-18-0393 · Cited by 13 · cited 1×
“The landmark Leuven trials (6, 7) suggested that strict glycemic control via intensive insulin therapy could reduce morbidity and mortality in critically ill patients, prompting intensive therapy strategies to achieve normoglycemia in ICU settings (8, 9).”
BackgroundGlycemic Control in the Pediatric Intensive Care Unit of Leuven: Two Years of Experience
Herpe, T. V., Vanhonsebrouck, K., Mesotten, D., Moor, B. D., & den Berghe, G. V. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600103 · Cited by 10 · cited 1×
“Waiting for laboratory results is especially problematic for pediatric and neonate patients, who have lower blood glucose targets and higher insulin sensitivity, compared with adults, that predispose these patients to hypoglycemia and necessitate close scrutiny (4).”
BackgroundZhu, W., Jiang, L., Jiang, S., Ma, Y., & Zhang, M. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006579 · Cited by 9
Louie, R. F., Curtis, C. M., Toffaletti, J. G., Handel, E. A., Slingerland, R. J., Fokkert, M. J., Muller, W., Weinert, S. E., Lee, D. M., & Kotagiri, S. (2015) · Point of Care The Journal of Near-Patient Testing & Technology · doi:10.1097/poc.0000000000000045 · Cited by 6 · cited 2×
“(27) demonstrated good performance of the ACCU-CHEK Inform II system when testing remnant arterial and venous whole blood samples from patients who were critically ill, revealing a strong correlation with both hexokinase and hospital laboratory PCA-HK reference methods.”
Methodden Berghe, G. V. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2013.220715 · Cited by 5 · cited 2×
“Hispanic/Latino 91 (24) 52 (11) 3 (3) 146 (15)”
Background
Research works printed but not linked: 1
- Li, 2017, Glucose monitoring and management in the NICU—how are we doing?, Infant, 13, 182
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 203
Diagnostic Modalities in Critical Care: Point-of-Care Approach
Rajšić, S., Breitkopf, R., Bachler, M., & Treml, B. (2021) · Diagnostics · doi:10.3390/diagnostics11122202 · Cited by 65
“Blood glucose can be measured with diverse POC glucose meters, from capillary BG analysis, or integrated in the blood gas analysis to continuous inline glucose measurement [61].”
MethodPark, E., & Kim, M. S. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0012 · Cited by 19
“Tran and colleagues evaluated the accuracy of the Accu-Chek Inform II compared with the perchloric acid hexokinase comparator method on the Cobas 6000 analyzer in critically ill patients; Accu-Chek Inform II showed 97%–98% of results within –15 mg/dL.(19) Except for the calibration data, the CGM values were paired wit…”
What, why and how to monitor blood glucose in critically ill patients
Juneja, D., Deepak, D., & Nasa, P. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.528 · Cited by 22
Metadata
- Authors
- Nichols, J. H., Brandler, E. S., Fantz, C. R., Fisher, K., Goodman, M. D., Headden, G., Hoppensteadt, D., Matika, R., Peacock, W. F., Rodrigo, J., Schützenmeister, A., Swanson, J. R., Canada-Vilalta, C., Miles, G., & Tran, N.
- Affiliations
- Vanderbilt University (US)
- Stony Brook University Hospital (US)
- Roche (United States) (US)
- Duke Medical Center (US)
- University of Cincinnati Medical Center (US)
- Medical University of South Carolina (US)
- Loyola University Medical Center (US)
- Banner - University Medical Center Tucson (US)
- Ben Taub Hospital (US)
- UC Davis Health (US)
- Roche Diagnostics GmbH, Penzberg, Germany
- University of Virginia Children's Hospital (US)
- Roche Diagnostics Corporation, Clinical Operations, Indianapolis, IN, USA
- Corresponding author
- Tran, Nam
- ORCID
- Venue
- The Journal of Applied Laboratory Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-06-05
- Volume
- 6
- Issue
- 4
- Pages
- 820-833
- ISSN
- 2475-7241 (ISSN-L)
- 2576-9456
- OpenAlex
- W3146691987
- Semantic Scholar
- 8835922280f48330b24fc295aa610f5a3a5874c4
- Cited by
- 19
- References
- 21
- Citations by year
- 2026: 3 · 2025: 5 · 2023: 7 · 2022: 1 · 2021: 3
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Applied Laboratory Medicine (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Roche Diagnostics International Ltd
- Rotkreuz
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- critically ill patients, blood glucose monitoring, arterial blood glucose, venous blood glucose, pediatric intensive care, intensive care unit, insulin dosing errors, diagnostic accuracy, Monte Carlo simulation
- MeSH terms
- Adult, Blood Glucose, Child, Critical Care, Humans, Infant, Newborn, Blood Glucose Self-Monitoring, Critical Illness, Point-of-Care Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.